Page last updated: 2024-11-02

phenylbutazone and Fatty Liver with Encephalopathy

phenylbutazone has been researched along with Fatty Liver with Encephalopathy in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Research Excerpts

ExcerptRelevanceReference
" About 50% of patients given salicylate in full anti-inflammatory dosage develop minor abnormalities of liver function."2.37Liver damage with non-narcotic analgesics. ( Prescott, LF, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prescott, LF1

Reviews

1 review available for phenylbutazone and Fatty Liver with Encephalopathy

ArticleYear
Liver damage with non-narcotic analgesics.
    Medical toxicology, 1986, Volume: 1 Suppl 1

    Topics: Acetaminophen; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver

1986